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SUMMARY
Mitochondria form close physical associations with
the endoplasmic reticulum (ER) that regulate a num-
ber of physiological functions. One mechanism by
which regions of ER are recruited to mitochondria
involves binding of the ER protein VAPB to the
mitochondrial protein PTPIP51, which act as scaf-
folds to tether the two organelles. Here, we show
that the VAPB-PTPIP51 tethers regulate autophagy.
We demonstrate that overexpression of VAPB or
PTPIP51 to tighten ER-mitochondria contacts im-
pairs, whereas small interfering RNA (siRNA)-medi-
ated loss of VAPB or PTPIP51 to loosen contacts
stimulates, autophagosome formation. Moreover,
we show that expression of a synthetic linker protein
that artificially tethers ER and mitochondria also re-
duces autophagosome formation, and that this artifi-
cial tether rescues the effects of siRNA loss of VAPB
or PTPIP51 on autophagy. Thus, these effects of
VAPB and PTPIP51 manipulation on autophagy are
a consequence of their ER-mitochondria tethering
function. Interestingly, we discovered that tightening
of ER-mitochondria contacts by overexpression
of VAPB or PTPIP51 impairs rapamycin- and torin
1-induced, but not starvation-induced, autophagy.
This suggests that the regulation of autophagy by
ER-mitochondria signaling is at least partly depen-
dent upon the nature of the autophagic stimulus.
Finally, we demonstrate that the mechanism by
which the VAPB-PTPIP51 tethers regulate auto-
phagy involves their role in mediating delivery of
Ca2+ to mitochondria from ER stores. Thus, our find-
ings reveal a new molecular mechanism for regu-
lating autophagy.
INTRODUCTION
Macroautophagy, hereafter termed autophagy, is an evolution-
arily conserved cellular process by which cytosolic constituents,
including damaged organelles and aggregated proteins, are en-
gulfed within specialized double-membrane vesicles known as
autophagosomes. These then fuse with the endosomal-lyso-
somal system, and this facilitates degradation of their contents
to yield metabolites that can be released into the cytoplasm for
recycling [1]. Autophagy occurs at basal levels in virtually all
cells, and this autophagic flux permits the removal of cellular
components that accumulate during normal cell functions [1].
In addition, autophagy provides amechanism bywhich cell com-
ponents are removed in certain physiological states, such as
during development and following nutrient starvation, but is
also a key process in some diseases. Indeed, alterations to auto-
phagy are believed to contribute to cancer and neurodegenera-
tive diseases [2].
Autophagosome formation commences with the development
of an initial cup-shaped isolationmembrane known as the phago-
phore, which expands to progressively engulf the cytosolicmate-
rial destined for degradation [1]. Once the phagophoremembrane
has sealed to surround the target material, the autophagosome
fuses with a lysosome (or endosome and then a lysosome) to
formanautolysosome, and thecontents are thendigested to yield
metabolites that can be released into the cytoplasm for recycling
[1]. Although many aspects of the autophagic process are now
becoming clear, the source(s) of the autophagosomal membrane
are still not fully known. The plasmamembrane, Golgi, mitochon-
dria, and inparticular theERhaveall beenproposedasmembrane
sources, and indeed, it is possible that all participate in autopha-
gosome formation, depending upon the nature of the cellular con-
tent that is destined for destruction [3].
With regard to the endoplasmic reticulum (ER), attention has
focused on the precise ER sub-region that might contribute to
autophagosome biogenesis. The ER is a dynamic structure
organized into distinct domains, which include rough and
smooth ER, flat membranes (sheets), and tubules [4]. This dy-
namic nature facilitates the interaction of ER membranes with
other organelle membranes, such as mitochondria, endosomes,
the Golgi, peroxisomes, and the plasma membrane [5]. The
regions of ER that form associations with mitochondria are
termed mitochondria-associated ER membranes (MAM), and
these have been the focus of much recent attention. Up to about
20% of the mitochondrial surface is closely apposed (10- to
30-nm distances) to ER membranes, and these contacts regu-
late many fundamental physiological processes, including Ca2+
homeostasis, phospholipid metabolism, energy metabolism,
mitochondrial biogenesis and trafficking, ER stress and the
unfolded protein response (UPR), apoptosis, and inflammatory
responses [6, 7].
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Figure 1. siRNA Knockdown of VAPB or PTPIP51 Increases Autophagic Structures
(A) Immunoblots showing siRNA knockdown of VAPB and PTPIP51 in HeLa cells. Cells were untreated (UT) or treated with either control (CTRL), VAPB, or
PTPIP51 siRNAs and samples probed for PTPIP51, VAPB, or a-tubulin as a loading control. Protein molecular mass markers are indicated in kD.
(B) siRNA knockdown of VAPB or PTPIP51 increases LC3-II levels in HEK293 cells. Cells were UT or treated with either CTRL, VAPB, or PTPIP51 siRNAs and
samples probed for PTPIP51, VAPB, LC3, or a-tubulin as a loading control. Both LC3-I and LC3-II isoforms are shown; arrow indicates LC3-II isoform. Bar chart
shows relative LC3-II levels following quantification of signals from immunoblots. LC3-II levels were normalized to a-tubulin signals. Protein molecular mass
markers are indicated in kD. Data were analyzed by one-way ANOVA and Tukey’s post hoc test; n = 5. Error bars are SEM; *p% 0.05.
(C) siRNA knockdown of VAPB or PTPIP51 increases autophagic structures in HeLa cells. Cells were transfected with CTRL, VAPB, or PTPIP51 siRNAs and the
numbers of ULK1, ATG5, EGFP-DFCP1, and EGFP-LC3 autophagic structures quantified. Representative confocal images of cells are shown with DAPI-labeled
(legend continued on next page)
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The mechanisms by which regions of ER come into contact
with mitochondria to form MAM are not properly understood,
but electron microscopy (EM) studies reveal the presence of
structures that appear to tether the two organelles [8]. Recently,
the integral ER protein vesicle-associated membrane protein-
associated protein B (VAPB) was shown to bind to the outer
mitochondrial membrane protein, protein tyrosine phosphatase
interacting protein 51 (PTPIP51) to form at least some of these
tethers [9]. Evidence to demonstrate that VAPB and PTPIP51
are ER-mitochondria tethers comes from multiple experimental
approaches. First, VAPB is an ER protein enriched in MAM,
and PTPIP51 is a known outer mitochondrial membrane protein
[6, 10]. Second, VAPB and PTPIP51 interact in a large number of
different biochemical assays [9–12]. Third, modulating expres-
sion of VAPB or PTPIP51 affects Ca2+ exchange between the
two organelles, which is a physiological readout of ER-mito-
chondria contacts [9, 10]. Finally, manipulating VAPB and/or
PTPIP51 expression induces appropriate changes in ER-mito-
chondria contacts as assayed in the EM; VAPB or PTPIP51 small
interfering RNA (siRNA) knockdown decreases, whereas overex-
pression markedly increases ER-mitochondria contacts [9, 13].
High-resolution imaging, such as EM, is required to properly
quantify ER-mitochondria contacts of 10- to 30-nmdistances [6].
Here, we address the role of MAM and the VAPB-PTPIP51
tethers in autophagy. We show that experimental manipulation
of VAPB and PTPIP51 expression to increase and decrease
ER-mitochondria associations impacts markedly upon both
basal and chemically induced autophagy. We also show that
these effects of VAPB andPTPIP51 on autophagy are dependent
upon their ER-mitochondria tethering functions because artificial
tethering of the two organelles rescues autophagy changes
induced by loss of the VAPB-PTPIP51 tethers. Finally, we
demonstrate that the mechanism by which the VAPB-PTPIP51
tethers regulate autophagy involves their key role in mediating
delivery of Ca2+ to mitochondria from ER stores. Our findings
reveal a new molecular mechanism for regulating autophagy.
RESULTS
siRNA Loss of VAPB and PTPIP51 Induces Autophagy
To gain insight into the role of ER-mitochondria associations in
autophagy, we first downregulated VAPB or PTPIP51 expression
using siRNAs and monitored basal levels of autophagy in HeLa
and HEK293 cells. HeLa and HEK293 cells have been used in
many studies of autophagy, e.g. [14, 15]. Such siRNA loss of
VAPB and PTPIP51 has been shown to markedly reduce ER-mi-
tochondria contacts in a variety of cell types [9, 10].We used pre-
viously characterized siRNAs, and in agreement with earlier
studies, these siRNAs led to an approximate 90% reduction in
VAPB and PTPIP51 expression in both cell lines (Figures 1A
and 1B). To monitor autophagy, we quantified the number of au-
tophagic structures that were present in cells using markers that
are recruited to the phagophore and form the autophagosome at
different stages. These markers were ULK1, which is one of the
earliest proteins recruited to the phagophore; double FYVE-
containing protein 1 (DFCP1), which is another early marker of
the phagophore; ATG5, which forms a complex with ATG12 to
mediate autophagosome elongation; and finally LC3, which is
the most commonly used marker for monitoring autophagy
and which is present from the later stages of autophagosome
formation to the autolysosome [14]. Endogenous ULK1 and
ATG5 were detected by immunostaining, whereas DFCP1 and
LC3 were detected by transfection of EGFP-tagged proteins.
Loss of VAPB or PTPIP51 induced amarked increase in the num-
ber of structures labeled by all of these autophagy markers
(Figure 1C).
To complement these light microscopy studies, we also moni-
tored how siRNA loss of VAPB or PTPIP51 affected autophago-
some numbers as detected by EM. EM has been used in many
studies of autophagy [14, 16]. In the EM, autophagic vacuoles
are discernible as double-membrane vacuoles containing en-
gulfed cytosolic contents or heterogeneous electron-dense
structures with undigested material; these features permit
detection and quantification of autophagic vacuoles [14, 16].
EM confirmed that loss of VAPB or PTPIP51 increased the num-
ber of autophagic vacuoles (Figure 1D).
The increases in autophagic structures seen following loss
of VAPB and PTPIP51 in the above assays could be due to an
induction of autophagy or, alternatively, be the consequence
of reduced autophagosome turnover. To address this issue,
we monitored LC3-II formation by immunoblotting in VAPB and
PTPIP51 siRNA knockdown HeLa cells that were also treated
with saturating levels of bafilomycin A1. Bafilomycin A1 is an in-
hibitor of the vacuolar H+-ATPase and so inhibits lysosomal acid-
ification and the fusion between autophagosomes and lyso-
somes so as to block LC3-II degradation; as such, bafilomycin
A1 treatment can aid in monitoring autophagosome synthesis
[17]. As was the case with HEK293 cells (Figure 1B), siRNA
loss of VAPB and PTPIP51 increased the amounts of LC3-II in
HeLa cells (Figure 2A). Moreover, LC3-II levels in the presence
of bafilomycin A1 increased in control siRNA cells, but this in-
creasewas augmented in VAPB andPTPIP51 siRNA knockdown
cells, suggesting that loss of VAPB and PTPIP51 stimulates au-
tophagic flux (Figure 2A). To test this further, we monitored ag-
gregation of a widely used model autophagy substrate, EGFP-
tagged huntingtin exon 1 containing 74 polyglutamine repeats
(EGFP-HDQ74) [18]. In agreement with previous studies, trans-
fected EGFP-HDQ74 formed clearly discernible aggregates in
some untreated or control-siRNA-treated cells [18]. However,
the numbers of these aggregates were significantly decreased
in VAPB and PTPIP51 siRNA knockdown cells (Figure 2B).
Loss of VAPB and PTPIP51 therefore appears to enhance
nuclei; scale bars are 10 mm. Bar charts show quantification of autophagic structures (dots/cell). Data were analyzed by one-way ANOVA and Tukey’s post hoc
test. For ULK1, EGFP-DFCP1, and ATG5, n = 45–200 cells; for EGFP-LC3, n = 401–466 cells per condition in five independent experiments. Error bars are SEM;
*p% 0.05; ***p% 0.001.
(D) siRNA knockdown of VAPB or PTPIP51 increases the number of autophagic structures detected in the EM. Representative EM images of UT HeLa cells or
cells treated with CTRL, VAPB, or PTPIP51 siRNAs as indicated are shown. Both low- and high-power (zoom) images are displayed. Arrows indicate autophagic
structures. The scale bar represents 500 nm. The bar chart shows number of autophagic structures/mm2. Data were analyzed by one-way ANOVA and Tukey’s
post hoc test. n = 15–17 cells. Error bars are SEM; ***p% 0.001.
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clearance of EGFP-HDQ74 aggregates, which is consistent with
the effects of VAPB or PTPIP51 loss in the LC3 turnover assays.
Collectively, these findings demonstrate that loss of VAPB and
PTPIP51 to reduce ER-mitochondria associations stimulates
autophagy flux.
Overexpression of VAPB and PTPIP51 Impairs
Autophagy
We next enquired how increasing ER-mitochondria associations
affected autophagy. To do so, we co-transfected cells with either
control vector, VAPB, or PTPIP51 and EGFP-LC3 as a marker
for autophagic structures. Such overexpression of VAPB or
PTPIP51 has been shown tomarkedly increase ER-mitochondria
contacts [9, 13]. Transfection of VAPB or PTPIP51 both
decreased the number of EGFP-LC3 autophagic structures
in the cells (Figure 3A). Moreover, whereas treatment of the
cells with bafilomycin A1 to block LC3 degradation markedly
increased the number of EGFP-LC3 structures in cells
transfected with control vector, this increase was significantly
reduced in the VAPB or PTPIP51 co-transfected cells (Figures
3A and 3B).
To complement these findings, we enquired how overexpres-
sion of VAPB or PTPIP51 affected LC3-II levels by immuno-
blotting. LC3-II levels were reduced in VAPB- and PTPIP51-
transfected cells, but whereas treatment with bafilomycin A1
increased the levels of LC3-II in control cells, the magnitude of
this increase was reduced in VAPB- and PTPIP51-transfected
cells (Figure 3C). These effects of bafilomycin A1 suggest that
the overexpression of VAPB and PTPIP51 inhibits autophago-
some production.
To test this possibility further, we monitored how overexpres-
sion of VAPB or PTPIP51 affected aggregation of EGFP-
HDQ74. Cells were co-transfected with EGFP-HDQ74 and either
control vector, VAPB, or PTPIP51 and the number of cells with
EGFP-HDQ74 aggregates quantified. Co-transfection of VAPB
or PTPIP51 both increased the proportion of cells containing
A
B
Figure 2. siRNA Knockdown of VAPB or PTPIP51 Induces Autophagic Flux
(A) HeLa cells were treated with CTRL VAPB or PTPIP51 siRNAs and treated with either vehicle or bafilomycin A1 (±BafA1) as indicated and samples then probed
on immunoblots for LC3 and a-tubulin as a loading control. Both LC3-I and LC3-II isoforms are shown; arrow indicates LC3-II isoform. Bafilomycin A1 increases
the levels of LC3-II in control, VAPB, and PTPIP51 siRNA knockdown cells. Bar chart shows relative LC3-II levels following quantification of signals from im-
munoblots. LC3-II levels were normalized to a-tubulin signals. Protein molecular mass markers are indicated in kD. Data were analyzed by one-way ANOVA and
Tukey’s post hoc test; n = 5 (vehicle) and n = 3 (bafilomycin A1). Error bars are SEM; *p% 0.05; **p% 0.01; ***p% 0.001.
(B) siRNA knockdown of VAPB or PTPIP51 decrease EGFP-HD74Q aggregation. Representative images of HEK293 cells transfected with EGFP-HDQ74 and
either UT or treated with CTRL, VAPB, or PTPIP51 siRNAs are shown. Cells were analyzed 48 hr post EGFP-HDQ74 transfection. Arrows indicate cells containing
EGFP-HDQ74 aggregates. Blue represents DAPI staining of nuclei. The scale bar represents 10 mm. Bar chart shows percentage of EGFP-HD74Q transfected
cells displaying aggregates. Data were obtained from 300–550 EGFP-HD74Q-transfected cells per condition in three independent experiments. Data were
analyzed by one-way ANOVA and Tukey’s post hoc test. Error bars are SEM; *p% 0.05.
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Figure 3. VAPB or PTPIP51 Overexpression Inhibits Basal Autophagy and Autophagic Flux
(A and B) Representative images of HEK293 cells co-transfected with EGFP-LC3 and either control empty vector (CTRL), Myc-VAPB, or HA-PTPIP51 and treated
with either vehicle (A) or bafilomycin A1 (BafA1) (B) as indicated. Cells were immunostained for VAPB andPTPIP51 via their epitope tags and LC3 visualized via the
EGFP tag. Transfection of VAPB or PTPIP51 decreases the numbers of EGFP-LC3 structures in both vehicle- and bafilomycin A1-treated cells. The scale bars
represent 10 mm. The bar charts show numbers of EGFP-LC3 dots per cell in the different experiments. Data were analyzed by one-way ANOVA and Tukey’s post
hoc test. n = 100–130 cells per condition from three independent experiments. Error bars are SEM; **p% 0.01; ***p% 0.001.
(C) VAPB or PTPIP51 overexpression inhibits autophagic flux. HeLa cells were transfected with either control empty vector (CTRL), Myc-VAPB, or HA-PTPIP51
and treated with either vehicle () or bafilomycin A1 (BafA1+) as indicated. Samples were then probed on immunoblots for LC3 and a-tubulin as a loading control.
Protein molecular mass markers are indicated in kD. Both LC3-I and LC3-II isoforms are shown; arrow indicates LC3-II isoform. Also shown are immunoblots
for PTPIP51 and VAPB, which were detected via their epitope tags. VAPB and PTPIP51 expression decreases the levels of LC3-II in both vehicle- and
(legend continued on next page)
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EGFP-HDQ74 aggregates, which is again consistent with a
decrease in autophagy (Figure 3D).
Expression of EGFP-HDQ74 is toxic to cells, and autophagic
clearance of EGFP-HDQ74 is protective against this toxicity
[18]. We therefore investigated how modulating expression of
VAPB and PTPIP51 affected EGFP-HDQ74 toxicity by moni-
toring DAPI-stained nuclear morphology. Fragmented or py-
knotic nuclei have been shown to be specific markers for cell
death in EGFP-HDQ74-expressing cells, which shows a very
high correlation with propidium iodide staining of live cells
[18]. Compared to control vector, overexpression of VAPB or
PTPIP51 both significantly increased the number of EGFP-
HDQ74-transfected cells displaying abnormal nuclei (EGFP-
HDQ74+control 8.1 ± 1.8, EGFP-HDQ74+VAPB 17.3 ± 2.0
abnormal nuclei, p % 0.01, Student’s t test; EGFP-HDQ74+
control 8.1 ± 1.8, EGFP-HDQ74+PTPIP51 21.2 ± 6.4 abnormal
nuclei, p% 0.05, Student’s t test; n = 468–610 cells). By contrast,
siRNA loss of PTPIP51 reduced the numbers of EGFP-HDQ74
cells displaying abnormal nuclei (EGFP-HDQ74+control 11.0 ±
1.2; EGFP-HDQ74+PTPIP51 siRNA 4.7 ± 0.6 abnormal nuclei;
p % 0.05; Student’s t test; n = 361–440 cells). siRNA loss of
VAPB showed a trend toward reducing the number of EGFP-
HDQ74 cells displaying abnormal nuclei, but this did not reach
significance. However, caution must be taken in interpreting
such results as being solely linked to EGFP-HDQ74 toxicity.
Tightening and loosening of ER-mitochondria contacts for
extended periods are both predicted to be detrimental to cells.
Tightening can induce Ca2+ overload in mitochondria, which
leads to opening of the mitochondrial permeability transition
pore and signaling for apoptosis; loosening reduces the ability
of mitochondria to generate ATP [6, 7]. Such effects may
contribute to cellular toxicity via routes that are independent of
EGFP-HDQ74 autophagic clearance.
Overexpression of VAPB and PTPIP51 Impairs
Rapamycin- and Torin-1-Induced, but Not
Starvation-Induced, Autophagy
The above studies show that overexpression of VAPB or
PTPIP51 to increase ER-mitochondria associations leads to
a reduction in basal autophagy. To determine the effects of
VAPB and PTPIP51 overexpression on chemically induced
autophagy, we quantified the numbers of EGFP-LC3 and
EGFP-DFCP1 autophagic structures in co-transfected cells
with either control vector, VAPB, or PTPIP51 and treated with
vehicle, rapamycin, or torin 1. Rapamycin and torin 1 are two
structurally distinct compounds that induce autophagy by inhib-
iting the mammalian target of rapamycin (mTOR); mTOR nega-
tively regulates autophagy [19]. As expected, rapamycin and
torin 1 markedly increased the numbers of EGFP-LC3 structures
in control-transfected cells (rapamycin: numbers of structures in
vehicle-treated cells 3.6 ± 0.4, number of structures in rapamy-
cin-treated cells 5.7 ± 1.2, p % 0.05, Student’s t test; torin A:
number of structures in vehicle-treated cells 3.9 ± 0.6, number
of structures in torin 1-treated cells 12.7 ± 3.1, p % 0.01, Stu-
dent’s t test; 80–100 cells were analyzed per condition from three
independent experiments). However, these effects of rapamycin
and torin 1were significantly reduced in cells co-transfectedwith
either VAPB or PTPIP51 (Figures 4A and 4B). Likewise, rapamy-
cin and torin 1 markedly increased the numbers of EGFP-DFCP1
structures in control-transfected cells (rapamycin: numbers of
structures in vehicle-treated cells 17.7 ± 9.6, number of struc-
tures in rapamycin-treated cells 26.9 ± 15.7, p% 0.05, Student’s
t test; torin A: number of structures in vehicle-treated cells 17.7 ±
9.6, number of structures in torin 1-treated cells 60.4 ± 29.3,
p % 0.01, Student’s t test; 75–100 cells were analyzed per
condition from three independent experiments). Again, these
effects of rapamycin and torin 1 were significantly reduced in
cells co-transfected with either VAPB or PTPIP51 (Figures 4D
and 4E). Thus, consistent with the effects of VAPB and PTPIP51
on basal autophagy, overexpression of VAPB and PTPIP51 both
led to a reduction in the number of EGFP-LC3 and EGFP-DFCP1
autophagic structures in cells undergoing chemically induced
autophagy.
We also monitored how starvation-induced autophagy
was affected by overexpression of VAPB or PTPIP51. To do
so, we grew cells in media lacking all amino acids, as described
by others [15, 20, 21]. As expected, starvation significantly
increased the numbers of both EGFP-LC3 and EGFP-DFCP1
structures in transfected HEK293 cells (numbers of EGFP-LC3
in control cells 3.6 ± 2.5, number of EGFP-LC3 structures in
starved cells 9.2 ± 6, p % 0.05, Student’s t test; numbers of
EGFP-DFCP1 in control cells 23 ± 12.8, number of EGFP-
DFCP1 structures in starved cells 41.3 ± 36.2, p % 0.001, Stu-
dent’s t test; 74 to 75 cells were analyzed per condition from
three independent experiments). However, unlike autophagy
induced by rapamycin or torin 1, expression of VAPB or PTPIP51
had no effect on the number of EGFP-LC3 or EGFP-DFCP1
autophagic structures in cells undergoing starvation-induced
autophagy (Figures 4C and 4F).
The Effects of siRNA Loss of VAPB and PTPIP51 on
Autophagy Are Rescued by Artificial Tethering of ER and
Mitochondria
The above studies demonstrate that VAPB andPTPIP51 regulate
autophagy. However, they do not eliminate the possibility that
the effects of VAPB and PTPIP51 on autophagy are unrelated
to their ER-mitochondria tethering function and are due to
some other, as yet uncharacterized, function of these proteins.
We therefore monitored autophagosome formation in VAPB or
PTPIP51 siRNA knockdown cells, in which breaking of ER-mito-
chondria contacts was rescued by use of an artificial tether. This
tether comprises the outer-mitochondrial-membrane-targeting
bafilomycin-A1-treated cells. The bar chart shows relative LC3-II levels following quantification of signals from immunoblots. LC3-II levels were normalized to
a-tubulin signals. Data were analyzed by one-way ANOVA and Tukey’s post hoc test; n = 3. Error bars are SEM; *p% 0.05; **p% 0.01.
(D) VAPB and PTPIP51 expression increases EGFP-HD74Q aggregation in HEK293T cells. Cells were co-transfected with EGFP-HD74Q and either control empty
vector (CTRL), Myc-VAPB, or HA-PTPIP5 and immunostained for VAPB and PTPIP51 via their epitope tags. Cells were analyzed 48 hr post-transfection. Arrows
indicate cells containing EGFP-HDQ74 aggregates; blue represents DAPI staining of nuclei. The scale bar represents 10 mm. The bar chart shows percentage of
EGFP-HD74Q-transfected cells displaying aggregates. Data were obtained from 320-580 EGFP-HD74Q-transfected cells per condition from five independent
experiments. Data were analyzed by one-way ANOVA and Tukey’s post hoc test. Error bars are SEM; *p% 0.05; ***p% 0.001.
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Figure 4. VAPB and PTPIP51 Overexpression Inhibits Rapamycin- and Torin-1-Induced, but Not Starvation-Induced, Autophagy
(A–C) Representative images of HEK293T cells co-transfected with EGFP-LC3 and either control empty vector (CTRL), Myc-VAPB, or HA-PTPIP51 as indicated
and treated with rapamycin (A), torin 1 (B), or starvation (C). Cells were immunostained for VAPB and PTPIP51 via their epitope tags and LC3 visualized via the
(legend continued on next page)
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sequence of mitochondrial A-kinase anchor protein-1 and the
ER-targeting sequence of yeast ubiquitin-conjugating enzyme
E2 6, fused to the N and C termini, respectively, of red fluores-
cent protein (Mito-RFP-ER). Expression of Mito-RFP-ER has
been shown to artificially increase ER-mitochondria tethering
via these targeting sequences, and RFP permits identification
of transfected cells [8].
To first confirm that Mito-RFP-ER increases ER-mitochondria
tethering in our hands, we monitored its effect on ER-mitochon-
dria associations using proximity ligation assays. For these, we
utilized antibodies to the inositol 1,4,5-trisphosphate (IP3) recep-
tor3 and the voltage-dependent anion channel (VDAC1) because
IP3 receptors located in MAM form a functional connection with
the outer mitochondrial membrane protein VDAC1 to facilitate
Ca2+ exchange between the two organelles [6, 7]. The distances
detected by proximity ligation assays are similar to those de-
tected by resonance energy transfer between fluorophores
(i.e., approximately 10 nm) [22], and so these assays are suitable
for detection of ER-mitochondria contacts. Indeed, proximity
ligation assays, including ones for the IP3 receptor and
VDAC1, have already been used to quantify ER-mitochondria as-
sociations [10, 12, 23].
To demonstrate the specificity of the proximity ligation assays,
we first performed control experiments in which primary IP3
receptor3 and/or VDAC1 antibodies were omitted. Omission of
primary antibodies produced none or only very few signals,
whereas inclusion of both antibodies generated large numbers
of signals (IP3 receptor3 antibody only: 0.209 ± 0.048 signals/
cell, n = 105 cells; VDAC1 antibody only: 0.085 ± 0.029 sig-
nals/cell, n = 94 cells; IP3 receptor3+VDAC1 antibodies
61.35 ± 5.43 signals/cell, n = 55 cells; from three independent
experiments). As expected, siRNA loss of VAPB or PTPIP51
decreased whereas expression of Mito-RFP-ER increased IP3
receptor3-VDAC1 proximity ligation assay signals in cells (Fig-
ure S1). Moreover, expression of Mito-RFP-ER partially rescued
the effects of loss of VAPB or PTPIP51 on these signals
(Figure S1).
We therefore monitored how expression of Mito-RFP-
ER affected autophagosome formation in VAPB or PTPIP51
siRNA knockdown cells. To do so, we quantified the number
of EGFP-LC3 and EGFP-DFCP1 structures in HeLa cells as
described earlier (see Figure 1C). Compared to RFP control,
expression of Mito-RFP-ER alone decreased the number of
EGFP-LC3 and EGFP-DFCP1 structures, which demonstrates
further that increasing ER-mitochondria contacts inhibits auto-
phagosome formation (Figures 5A and 5B). However, whereas
loss of VAPB or PTPIP51 increased the numbers of EGFP-LC3
and EGFP-DFCP1 structures (in agreement with earlier studies;
Figure 1C), these increases were significantly reduced in cells
co-transfected with Mito-RFP-ER (Figures 5A and 5B). Thus,
the increases in autophagosome formation induced by loss of
VAPB or PTPIP51 expression are linked to the ER-mitochondria
tethering function of VAPB and PTPIP51.
We also monitored how expression of the Mito-RFP-ER artifi-
cial tether affected chemically and starvation-induced auto-
phagy. To do so, wemonitored the numbers of EGFP-LC3 struc-
tures in torin 1 and starved HEK293 cells that were also
transfected with Mito-RFP-ER. In agreement with studies on
the effects of the VAPB-PTPIP51 tethers on chemically and star-
vation-induced autophagy (Figure 4), expression of Mito-RFP-
ER reduced the numbers of EGFP-LC3 autophagic structures
in torin 1, but not starved cells (Figure S2).
The Effect of VAPB and PTPIP51 on Autophagy Involves
Their Role inMediating ER-Mitochondria Ca2+ Exchange
A primary function of ER-mitochondria contacts is to facilitate
delivery of Ca2+ to mitochondria from ER stores. A major route
for this delivery involves release of Ca2+ from IP3 receptors
located in MAM for uptake by mitochondria via VDAC and the
mitochondrial Ca2+ uniporter [6, 7]. The tight contacts between
ER and mitochondria at MAM facilitate this exchange because
they enable high local concentrations of Ca2+ (Ca2+ puffs) to be
achieved, which are sufficient to drive a response at the mito-
chondrial surface [6, 7].
A number of studies have now shown that reductions in IP3 re-
ceptor function and impaired Ca2+ uptake by mitochondria stim-
ulate autophagy [24–29]. Thus, the effects of VAPB and PTPIP51
on autophagy may be linked to Ca2+ exchange via MAM at ER-
mitochondria contact sites. To test this possibility further, we
first monitored whether siRNA knockdown or overexpression
of VAPB or PTPIP51 to decrease or increase ER-mitochondria
contacts, respectively, affected expression of key ER-mitochon-
dria Ca2+ exchange proteins. To do so, we probed immunoblots
of VAPB/PTPIP51-transfected/siRNA-treated HEK293 cells for
IP3 receptor, VDAC, or the mitochondrial Ca2+ uniporter. How-
ever, we detected no changes in expression of any of these pro-
teins in the VAPB or PTPIP51 siRNA knockdown or transfected
cells (Figures S3A and S3B). We next monitored whether
overexpression of VAPB or PTPIP51 affected IP3 receptor3-
VDAC1 interactions using proximity ligation assays. As pre-
dicted, expression of VAPB or PTPIP51 both led to increases
in IP3 receptor3-VDAC1 interactions (Figure 6A). These results
complement the effects of siRNA knockdown of VAPB or
PTPIP51, which induce reductions in IP3 receptor3-VDAC1 in-
teractions (Figure S1). Finally, wemonitored how overexpression
of VAPB or PTPIP51 affected uptake of Ca2+ by mitochondria
following IP3 receptor-mediated release from ER stores. For
these experiments, we used HEK293 cells co-transfected with
the M3 muscarinic-acetylcholine-receptor (M3R) and triggered
physiological IP3 receptor-mediated Ca2+ release by application
of the M3R agonist oxotremorine-M. In line with previous studies
on ER-mitochondria associations, we used HEK293 cells for
EGFP tag. The bar charts show number of EGFP-LC3 dots per cell in the different experiments. Data were analyzed by one-way ANOVA and Tukey’s post hoc
test. n = 80–192 cells per condition from three independent experiments. Error bars are SEM; ***p% 0.001; ns, not significant.
(D–F) Representative images of HeLa cells co-transfected with EGFP-DFCP1 and either control empty vector (CTRL), Myc-VAPB, or HA-PTPIP51 and treated
with rapamycin (D), torin 1 (E), or starvation (F). Cells were immunostained for VAPB and PTPIP51 via their epitope tags and DFCP1 visualized via the EGFP tag.
The bar charts show number of EGFP-DFCP1 dots per cell in the different experiments. Data were analyzed by one-way ANOVA and Tukey’s post hoc test.
n = 75–100 cells per condition from three independent experiments. Error bars are SEM; **p% 0.01; ***p% 0.001.
Scale bars represent 10 mm. See also Figure S2.
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these experiments because they do not express endogenous
M3R and so provide a useful model for monitoring mitochondrial
Ca2+ levels following its release from ER specifically in trans-
fected cells [9, 10, 12]. Transfection of VAPB or PTPIP51 both
induced significant increases in mitochondrial and correspond-
ing decreases in cytosolic Ca2+ levels in these experiments (Fig-
ure 6B). Again, these results complement previous studies that
show that siRNA knockdown of VAPB or PTPIP51 reduce mito-
chondrial and increase cytosolic Ca2+ levels following IP3-re-
ceptor-mediated Ca2+ release [10]. Thus, overexpression and
A
B
Figure 5. Artificially Tethering ER and Mitochondria by Transfection of Mito-RFP-ER Reduces the Effect of siRNA Loss of VAPB or PTPIP51
on Autophagosome Formation
(A) Representative images of HEK293 cells treated with either control, VAPB, or PTPIP51 siRNAs and then transfected with EGFP-LC3+control RFP or EGFP-
LC3+Mito-RFP-ER as indicated; arrows show non-transfected cells for comparison. The scale bars represent 10 mm.
(B) Representative images of HeLa cells treated with either control, VAPB, or PTPIP51 siRNAs and then transfected with EGFP-DFCP1+RFP or EGFP-
DFCP1+Mito-RFP-ER as indicated. The scale bars represent 10 mm.
The bar charts show quantification of EGFP-LC3 (A) and EGFP-DFCP1 (B) autophagic structures (dots/cell). Data were analyzed by Student’s t test. n = 71–264
cells per condition in three to five independent experiments. Error bars are SEM; *p% 0.05; **p% 0.01; ***p% 0.001. See also Figure S1.
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siRNA knockdown of VAPB and PTPIP51 to modulate ER-mito-
chondria contacts induce appropriate changes in IP3 receptor3-
VDAC1 interactions and IP3-receptor-mediated mitochondrial
Ca2+ uptake. Moreover, these changes do not involve alterations
to the levels of expression of IP3 receptor, VDAC, or the mito-
chondrial Ca2+ uniporter.
We therefore enquired whether the reductions in autophago-
some formation induced by overexpression of VAPB or PTPIP51
(Figure 3) involve stimulation of Ca2+ delivery to mitochondria
from IP3 receptors. To do so, we quantified the numbers of
EGFP-LC3 autophagic structures in cells co-transfected with
control vector, VAPB, or PTPIP51 and then treated with either
vehicle, Xestospongin C, or Ruthenium-360 to block ER-mito-
A
B
Figure 6. Overexpression of VAPB or
PTPIP51 Increases IP3 Receptor3-VDAC1
Interactions and ER-Mitochondria Ca2+
Exchange
(A) HeLa cells were transfected with control EGFP
vector, CFP-VAPB, or EGFP-PTPIP51 and prox-
imity ligation assays (PLAs) for IP3 receptor3-
VDAC1 interactions then performed. Representa-
tive images with PLA signals in the different
transfected cells are shown. The scale bar repre-
sents 10 mm. The bar chart shows quantification of
PLA signals. Data were analyzed by one-way
ANOVA and Tukey’s post hoc test. n = 77–142 cells
per condition from three independent experiments.
Error bars are SEM; ***p% 0.001.
(B) Cytosolic (upper) and mitochondrial (lower)
Ca2+ levels following oxotremorine-M (OxoM)-
induced Ca2+ release from ER stores. HEK293
cells were co-transfected with M3R and either
control empty vector (CTRL), Myc-VAPB, or HA-
PTPIP51 and treated with oxotremorine-M.
Representative traces of Fluo4 (cytosolic) and
Rhod2 (mitochondrial) fluorescence are shown on
the left, and normalized peak values are shown on
the right. Fluo4 and Rhod2 fluorescence shows
transient increases in cytosolic and mitochondrial
Ca2+ levels upon OxoM-induced Ca2+ release
from ER stores. Compared to control, VAPB and
PTPIP51 expression decreased peak cytosolic
and increased peak mitochondrial Ca2+ levels.
Data were analyzed by one-way ANOVA and
Tukey’s post hoc test. n = 48–81 cells from three
independent experiments. Error bars are SEM;
*p% 0.05; ***p% 0.001.
See also Figure S3.
chondria Ca2+ exchange. Xestospongin
C is a potent membrane-permeable IP3
receptor antagonist, and Ruthenium-360
is an inhibitor of the mitochondrial Ca2+
uniporter [28, 30]. To complement these
pharmacological studies, we also moni-
tored how siRNA loss of themitochondrial
Ca2+ uniporter affected the number of
EGFP-LC3 autophagic structures in the
VAPB- or PTPIP51-overexpressing cells.
This siRNA treatment induced an approx-
imate 90% reduction in expression of the
mitochondrial Ca2+ uniporter (Figure S4A).
Treatment with Xestospongin C, Ruthenium-360, or mitochon-
drial Ca2+ uniporter siRNAs all induced a significant increase in
EGFP-LC3 autophagic structures (Figure S4B). These results
are in line with previous studies that also show that inhibiting
IP3-receptor-mediated delivery of Ca2+ to mitochondria stimu-
lates autophagosome formation [24, 26–28, 31–33]. However,
the inhibitory effects of VAPB and PTPIP51 overexpression on
EGFP-LC3 autophagosome formation (Figure 3) were abrogated
in cells treated with Xestospongin C or Ruthenium-360 and in the
mitochondrial Ca2+ uniporter siRNA knockdown cells (Figure 7A).
Moreover, treatment of the cells with bafilomycin A1 to block
LC3 degradation not only confirmed that siRNA loss of the mito-
chondrial Ca2+ uniporter increased LC3-II levels, demonstrating
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AB
Figure 7. Inhibiting IP3 Receptor-Mediated Ca2+ Delivery to Mitochondria Abrogates the Effects of VAPB and PTPIP51 Overexpression on
Autophagosome Formation
(A) Representative images of HEK293 cells co-transfected with EGFP-LC3 and either myc-VAPB or HA-PTPIP51 and treated with either the IP3 receptor inhibitor
Xestospongin C, the mitochondrial Ca2+ uniporter (MCU) blocker Ruthenium-360 (Ru360), or MCU siRNAs. For MCU siRNAs, cells were first treated with siRNAs
and then transfected with plasmids. Cells were immunostained for VAPB and PTPIP51 via their epitope tags and LC3 visualized via the EGFP tag. The scale bars
represent 10 mm. Bar charts show numbers of EGFP-LC3 dots per cell in the different experiments. Data were analyzed by one-way ANOVA. n = 118–187 cells in
three or four independent experiments. Error bars are SEM.
(B) siRNA loss of MCU increases LC3-II levels and abrogates the effects of VAPB and PTPIP51 overexpression on LC3-II levels in bafilomycin-A1-treated HeLa
cells. Cells were treated with CTRL or MCU siRNAs, transfected with either myc-VAPB or HA-PTPIP51, and treated with bafilomycin A1 (BafA1) as indicated.
Samples were then probed on immunoblots for LC3, MCU, VAPB, PTPIP51, and a-tubulin as a loading control. VAPB and PTPIP51 were detected via their
epitope tags. Both LC3-I and LC3-II isoforms are shown; arrow indicates LC3-II isoform.Molecular massmarkers are indicated in kD. The bar chart shows relative
LC3-II levels following quantification of signals from immunoblots. LC3-II levels were normalized to a-tubulin signals. Data were analyzed by one-way ANOVA and
Tukey’s post hoc test; n = 3. Error bars are SEM; *p% 0.05; ***p% 0.001.
See also Figure S4.
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an induction of autophagy, but also revealed that this increase
was unaffected by overexpression of VAPB or PTPIP51 (Fig-
ure 7B). Thus, the inhibitory effects of VAPB and PTPIP51
overexpression on autophagy induction are completely abro-
gated by blocking IP3-receptor-mediated delivery of Ca2+ to
mitochondria.
DISCUSSION
Tight contacts between regions of ER and mitochondria regu-
late a number of fundamental physiological processes [6, 7].
One mechanism by which these contacts form involves the
tethering proteins VAPB and PTPIP51 [9, 10, 13]. Here, we
demonstrate that the VAPB-PTPIP51 tethers also regulate
autophagosome formation. We show that loosening ER-mito-
chondria contacts via loss of VAPB or PTPIP51 induces
whereas tightening contacts by overexpression of VAPB or
PTPIP51 impairs basal autophagy. We also show that chemical
induction of autophagy by treatment with rapamycin or torin 1
is impaired in VAPB- or PTPIP51-overexpressing cells. More-
over, we show that expression of a synthetic linker protein
that artificially tethers ER and mitochondria also reduces auto-
phagosome formation and that this artificial tether rescues the
effects of siRNA loss of VAPB or PTPIP51 on autophagy. Thus,
these effects of VAPB and PTPIP51 manipulation on autophagy
are associated with their ER-mitochondria tethering function
and not some as yet unknown alternative function of these
proteins.
Recently, others have also reported a role for ER-mitochon-
dria associations in autophagy and mitophagy [15, 20, 21, 34,
35]. Our findings provide novel mechanistic data to demon-
strate that ER-mitochondria contacts mediated by the VAPB-
PTPIP51 tethers regulate autophagy. There are, however,
some differences between these various studies. Notably, we
find that loosening of ER-mitochondria contacts induces auto-
phagosome formation, whereas some others report that such
loosening is inhibitory to their formation [15, 20, 21]. The rea-
sons for these dissimilar results may involve the different
experimental approaches utilized. For example, in our study,
we monitored basal and rapamycin-, torin 1-, and starvation-
induced autophagy, whereas others have focused solely on
autophagy induced by starvation [15, 20, 21]. Indeed, we
found differences in how autophagy induced by rapamycin/
torin 1 and starvation were affected by ER-mitochondria
tethering.
Additionally, different studies have used different methods to
experimentally manipulate ER-mitochondria contacts. In our
study, this involved the VAPB-PTPIP51 tethers, but other inves-
tigations manipulated mitofusin-2 and phosphofurin acidic clus-
ter sorting protein-2 (PACS-2) [15, 20, 21]. Both mitofusin-2 and
PACS-2 have also been linked to ER-mitochondria tethering [36–
38]. One possibility is that different tethering proteins mediate
recruitment of distinct ER domains to mitochondria (rough or
smooth ER, tubules, or sheets), and these may function to regu-
late autophagosome formation in different ways, with the precise
outcome varying according to the autophagic stimulus and the
nature of the structure targeted for autophagic clearance.
Setting aside these possibilities, the roles of mitofusin-2 and
PACS-2 as ER-mitochondria tethering proteins are unclear.
Thus, whereas some reports show that loss of mitofusin-2 re-
duces ER-mitochondria contacts [36, 38], other studies contra-
dict these findings and claim that such loss increases ER-mito-
chondria contacts [39–43]. Clearly, if mitofusin-2 loss increases
rather than decreases ER-mitochondria tethering, then prior ex-
periments involving loss of mitofusin-2 can be reinterpreted as
showing that increased ER-mitochondria associations reduce
autophagy.
Likewise, the precise role of PACS-2 in regulating ER-
mitochondria associations is not properly established.
PACS-2 is a multifunctional sorting protein involved in
inter-organelle trafficking in the secretory and endosomal
pathways [44]. In addition, it also translocates to the nucleus
to regulate SIRT1-mediated deacetylation of p53 [45]. How
these diverse functions link to ER-mitochondria associations
are unclear, and certainly, there is no direct evidence to
suggest that PACS-2 acts as an ER-mitochondria tethering
protein, such as VAPB or PTPIP51. Rather, PACS-2 may
function to somehow indirectly influence or regulate ER-
mitochondria associations. Additionally, PACS-2 impacts
upon mitochondrial morphology with loss of PACS-2 inducing
extensive mitochondrial fragmentation [37]. The diversity of
cell functions regulated by PACS-2 and these caveats
involving mitochondrial morphology query the validity of
concluding that changes in autophagosome formation
induced by loss of PACS-2 are due solely to disruption of
ER-mitochondria contacts.
Here, we investigated how altering ER-mitochondria associa-
tions via manipulating VAPB and PTPIP51 affects autophagy. As
detailed above (see Introduction), a number of lines of evidence
demonstrate that VAPB and PTPIP51 function as ER-mitochon-
dria tethers [9–13]. We also utilized an artificial tether to manipu-
late ER-mitochondria associations, and this produced comple-
mentary results to those involving VAPB and PTPIP51. Thus,
our approach provides a more direct and easily interpretable
route for probing the role of ER-mitochondria contacts in auto-
phagosome formation.
Our findings are also in line with a large number of studies
that show that disruption of Ca2+ transfer from MAM-located
IP3 receptors to mitochondria stimulates autophagy [24–29,
31, 32]. This, stimulation is proposed to represent a physiolog-
ical response of the cell to altered bioenergetics because
mitochondria require Ca2+ for efficient production of ATP
(several dehydrogenases in the tricarboxylic acid cycle are
Ca2+ regulated) [6, 7, 46]. A primary function of ER-mitochon-
dria contacts is to facilitate IP3-receptor-mediated delivery
of Ca2+ to mitochondria [6–8]. Consistent with these roles,
loss of VAPB or PTPIP51 reduces whereas overexpression
of VAPB or PTPIP51 increases mitochondrial Ca2+ uptake
following its release from IP3 receptors (Figure 6B) [9, 10].
Together, these findings suggest that the effects of VAPB
and PTPIP51 on autophagy are linked to their role in mediating
Ca2+ exchange between ER and mitochondria at contact sites.
In support of this, we found that the effects of VAPB and
PTPIP51 overexpression on autophagosome formation were
completely abrogated in cells treated with Xestospongin C,
Ruthenium-360, or siRNAs for the mitochondrial Ca2+ uni-
porter, which all inhibit IP3-receptor-mediated delivery of
Ca2+ to mitochondria. Thus, the mechanism by which the
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VAPB-PTPIP51 tethering proteins impact upon autophagy
involves their regulation of ER-mitochondria Ca2+ exchange
at MAM.
Of interest was our finding that increased ER-mitochondria
tethering induced by overexpression of VAPB, PTPIP51, or
the Mito-RFP-ER artificial tethers inhibited rapamycin- and torin
1-induced, but not starvation-induced, autophagy. Rapamycin
and torin 1 induce autophagy by selectively inhibiting mTOR
[19]. By contrast, starvation-induced autophagy is more com-
plex, involving mTOR and a variety of upstream nutrient-
sensing molecules, including AMP-activated protein kinase
and Ca2+-calmodulin-dependent protein kinase b [46]. Starva-
tion-induced, but not rapamycin-induced, autophagy is there-
fore dependent upon disruption of the BCL2-Beclin 1 interac-
tion [47]. Also, whereas numerous studies have shown that
blocking IP3-receptor-mediated delivery of Ca2+ to mitochon-
dria stimulates autophagy [24–29, 31, 32] (and results shown
here), paradoxically, starvation-induced autophagy requires
release of Ca2+ from sensitized IP3 receptors [48]. Thus, the
different effects of overexpression of VAPB, PTPIP51, and the
artificial tethers on starvation- and rapamycin/torin 1-induced
autophagy are probably due to differences in the signaling
mechanism by which these stimuli induce autophagy. Whatever
the precise scenario, the results described here demonstrate
that the VAPB-PTPIP51 tethers regulate basal and rapamycin-
and torin 1-induced autophagy and that this involves their role
in facilitating IP3-receptor-mediated delivery of Ca2+ from ER
stores to mitochondria.
Increasing evidence supports a role for autophagy in neurode-
generative diseases, and damage to ER-mitochondria signaling
is a feature of these diseases [2, 6, 49, 50]. It will therefore be
interesting to determine whether there are links between neuro-
degenerative disease insults, the VAPB-PTPIP51 tethers, and
autophagy. The results described here form the basis for such
studies.
EXPERIMENTAL PROCEDURES
Reagents
Details of plasmids, siRNAs, antibodies, and other reagents are described in
Supplemental Experimental Procedures.
Cell Culture, Transfection, SDS-PAGE, and Immunoblotting
Cells were transfected with plasmids, treated with siRNAs, and analyzed
by SDS-PAGE and immunoblotting essentially as described [9, 10, 12]. Full
details are provided in Supplemental Experimental Procedures.
Microscopy
Cells were fixed and analyzed by immunofluorescence microscopy and EM
essentially as previously described [9, 12]. Proximity ligation assays were per-
formed using a Duolink In Situ Far Red kit according to the manufacturer’s in-
structions (Sigma). Ca2+ measurements were obtained as described previ-
ously [9, 10, 12]. Confocal and wide-field images were acquired using Leica
TCS-SP5 and Leica DM5000B microscopes, EM images acquired using a
Tecnai 20 instrument, and Ca2+ measurements obtained with Zeiss Axiovert
S100 or Nikon Eclipse TiE microscopes. Full details of microscopy methods
and statistical and other analyses are provided in Supplemental Experimental
Procedures.
Statistical Analyses
Statistics were performed using GraphPad Prism.
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